| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 10/09/2002 | EP1246805A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 10/09/2002 | EP0973550B1 Antagonistic anti-avb3 integrin antibodies |
| 10/09/2002 | CN1373765A Calcium complex of phosphorus contg. ethylenediamine derivs. |
| 10/09/2002 | CN1373672A Blocking immune response to foreign antigen using antagonist which binds to CD20 |
| 10/09/2002 | CN1373671A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 10/09/2002 | CN1372982A Interstitial 3D radiotherapeutic system-internal gamma-knife for cancer operation |
| 10/08/2002 | US6461870 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
| 10/08/2002 | US6461806 Measuring isotope labelled dna synthesis and destruction; cancer diagnosis; prognosing human immunodeficiency virus |
| 10/08/2002 | US6461666 Radioactive balloon for dilation catheter system and process for preparation thereof |
| 10/08/2002 | US6461585 Preparation of radiolabelled haloaromatics via polymer-bound intermediates |
| 10/03/2002 | WO2002076497A2 Method and composition |
| 10/03/2002 | WO2002076491A1 Liposome targeting of matrix metalloproteinase inhibitors |
| 10/03/2002 | WO2002020062A3 Coated implant |
| 10/03/2002 | WO2001023385A9 Novel tropane analogs |
| 10/03/2002 | WO2001021106A9 Radioactive graft or cuff |
| 10/03/2002 | US20020143228 Radioactively coated devices |
| 10/03/2002 | US20020143012 For imaging amyloid deposits |
| 10/03/2002 | US20020142994 Bisphosphonate conjugates and methods of making and using the same |
| 10/03/2002 | US20020142049 Precipitating drug as solid |
| 10/03/2002 | US20020141998 Multi-partite ligands and methods of identifying and using same |
| 10/03/2002 | US20020141980 Convection-enhanced delivery of AAV vectors |
| 10/03/2002 | CA2441227A1 Liposome targeting of matrix metalloproteinase inhibitors |
| 10/02/2002 | EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 10/02/2002 | EP1244653A1 Non peptide tachykinin receptor antagonists |
| 10/02/2002 | EP1244638A2 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 10/02/2002 | CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands |
| 10/01/2002 | US6458935 Radiolabeled farnesyl-protein transferase inhibitors |
| 10/01/2002 | US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance |
| 10/01/2002 | US6458336 Detectably labeled porphyrin compound for identifying the sentinel lymph node |
| 10/01/2002 | US6458069 Multi layer radiation delivery balloon |
| 10/01/2002 | CA2213935C Diagnostic agent for diabetes |
| 10/01/2002 | CA2077670C Method for enhancing antibody transport through capillary barriers |
| 10/01/2002 | CA2068632C Nanocrystalline magnetic iron oxide particles, processes for their preparation and their use in medical diagnostics and therapy |
| 09/26/2002 | WO2002075004A1 Metal-zirconia composite coating |
| 09/26/2002 | WO2002074736A1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 09/26/2002 | WO2002074348A1 Dry powder compositions comprising labelled particles for inhalation |
| 09/26/2002 | WO2002074347A1 Technetium 99m-n2s2-congo red complexes utilizing diamide dithiolate ligand systems for radioimaging |
| 09/26/2002 | WO2002074346A2 Targeting chemical compounds to cells |
| 09/26/2002 | WO2002062780A3 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 09/26/2002 | WO2002036173A3 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 09/26/2002 | US20020137672 Radiolabeled annexins |
| 09/26/2002 | US20020137109 Anticarcinogenic agents;monitoring therapy efficiency |
| 09/26/2002 | US20020136769 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 09/26/2002 | US20020136719 For biomedical applications, including biological delivery to humans and animals |
| 09/26/2002 | US20020136690 Detection and treatment of infections with immunoconjugates |
| 09/26/2002 | US20020136688 Methods for treating AVM's using radioactive compositions |
| 09/26/2002 | CA2441111A1 Method for targeting chemical compounds to cells and pharmaceutical compositions used therein |
| 09/25/2002 | CN1371292A Radiopharmaceutical products and their preparation procedure |
| 09/24/2002 | US6455498 Structural alterations of the EGF receptor genes in human tumors |
| 09/24/2002 | US6455494 Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 09/24/2002 | US6455251 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455043 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 09/24/2002 | US6455026 Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors |
| 09/24/2002 | US6455025 Polysaccharide-peptide derivatives |
| 09/24/2002 | US6455024 Particles of an inorganic material containing a radionuclide and having a specified particle size in microns; radiotherapy |
| 09/24/2002 | CA2096223C Treatment for tissue ulceration |
| 09/19/2002 | WO2002073235A2 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072598A1 Steroids as agonists for fxr |
| 09/19/2002 | WO2002072143A1 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives |
| 09/19/2002 | WO2002072011A2 Stabilized therapeutic and imaging agents |
| 09/19/2002 | WO2002024695A3 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 09/19/2002 | WO2002010192A3 Somatostatin analogues |
| 09/19/2002 | WO2001076645A3 Targeted agents useful for diagnostic and therapeutic applications |
| 09/19/2002 | US20020133019 Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and vivo imaging and prevention of amyloid deposition |
| 09/19/2002 | US20020132278 Measuring level of pregnancy- associated plasma protein-A (PAPP-A) in biological sample from a non-pregnant patient; comparing level with that of control subjects; diagnosing inflammatory condition based on level of PAPP-Acontrol |
| 09/19/2002 | US20020131972 Multi-partite ligands and methods of identifying and using same |
| 09/19/2002 | US20020131935 Fibrin carrier compound for treatment of disease |
| 09/19/2002 | US20020131934 Diagnostic imaging agent useful for selecting a therapy for cancerous bone metastasis |
| 09/19/2002 | US20020131932 Radiopharmaceuticals for diagnosing alzheimer's disease |
| 09/19/2002 | US20020131931 Boat tropanes |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2440552A1 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 09/19/2002 | CA2440319A1 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives |
| 09/19/2002 | CA2439953A1 Stabilized therapeutic and imaging agents |
| 09/19/2002 | CA2433353A1 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/18/2002 | EP1240396A1 A ventilating device for ventilating through a ridge |
| 09/18/2002 | EP1239887A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 09/18/2002 | EP1239886A2 Labelled ascorbic acid derivatives |
| 09/18/2002 | EP1239874A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/18/2002 | CN1370161A Novel quaternary ammonium compounds, its prepn. methods and medicinal application |
| 09/18/2002 | CN1369498A Medical compound containing radioactive tin element and its preparing process |
| 09/18/2002 | CN1090973C TC-99m marked peptide for imaging |
| 09/17/2002 | US6451544 Identification of agents that protect against inflammatory injury to neurons |
| 09/17/2002 | US6451543 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 09/17/2002 | US6451314 MHC conjugates useful in ameliorating autoimmunity |
| 09/17/2002 | US6451312 Diagnosis, imaging; induction of endothelial cell surface antigens |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451284 Antibodies which target lymphoma cells which have a tendency to localize to the bone marrow. |
| 09/12/2002 | WO2002070555A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | WO2002070020A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | WO2002070018A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2001085218A3 Acylated cyclodextrin guest inclusion complexes |
| 09/12/2002 | WO2000067792A9 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 09/12/2002 | US20020128561 Locating marker/tracer elements detectable by neutron activated analysis within or on carrier microspheres, including microspheres used in biological experimentation |
| 09/12/2002 | US20020128553 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 09/12/2002 | US20020127287 Administering biologically active lipophilic ginkgolides and derivatives and food ingredient modulating phospholipid metabolism for protecting neuronal cells for therapy and prophylaxis of mental or neuronal disorders |